Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

NCT00760877

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site St Leonards, New South Wales, Australia
  • Novartis Investigative Site Westmead, New South Wales, Australia
  • Novartis Investigative Site Herston, Queensland, Australia
View all 30 locations
View Trial Details
Completed

Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

NCT00121303

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • North Hampshire Hospital Basingstoke, England, United Kingdom
  • Kent and Canterbury Hospital Canterbury, England, United Kingdom
  • Medway Maritime Hospital Gillingham Kent, England, United Kingdom
  • Maidstone Hospital Maidstone, England, United Kingdom
View Trial Details
Completed

Patient Reported Outcomes in Chronic Myeloid Leukemia

NCT01252589

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Dana-Farber Cancer Institute Harvard University Boston, Massachusetts, United States
  • Innsbruck University Hospital Innsbruck, Austria
  • University of Ghent Ghent, Belgium
  • Centre Hospitalier Universitaire of Poitiers Poitiers, France
View all 14 locations
View Trial Details
Completed

Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia

NCT01870596

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +25 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States
  • Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details

Related conditions